Welcome to this week’s edition of Weekend Wonderings. I hope that you have a nice, enjoyable Easter weekend and get ample “family” time. So, if you’re reading this on Sunday, I appreciate it, but get back to your family. You can catch this later Sunday or Monday.. Oh, and if you’re visiting, safe travels to you. Regardless, grab whatever beverage that you need and let’s proceed.
Study Identifies a Likely Key Driver of Colorectal Cancer Development and Progression
A new study identifies a molecule that is a probable driving force in colorectal cancer and suggests that the molecule could be an important target for colorectal cancer treatment and a valuable biomarker of tumor progression.
“We found that miR-135b is up-regulated in both sporadic and inflammatory bowel disease-associated colorectal cancer, and that its up-regulation is associated with tumor stage and poor clinical outcome,” says principal investigator Carlo M. Croce, MD, chair of molecular virology, immunology and medical genetics, and director of Human Cancer Genetics at Ohio State and the OSUCCC – James.
Some more progress in James-led research. We’ve got to keep ahead of this stuff..
New Emergency Department at The James
The new James/Wexner will have an Emergency Department geared towards the special conditions experienced by cancer patients.